```html

Xanthopsia After Cataract Surgery

What is Xanthopsia after cataract surgery?

Xanthopsia is a visual disturbance in which objects appear yellow‑tinted. When it occurs after cataract surgery, patients notice a persistent or intermittent yellow hue over the entire visual field, sometimes described as “looking through a yellow filter.” The condition is usually temporary, but in some cases it can persist for weeks or months, causing discomfort, difficulty with colour discrimination, and reduced visual performance.

During cataract surgery the natural cloudy lens is removed and replaced with an artificial intra‑ocular lens (IOL). The new lens, the surgical technique, and the healing process can all influence the way light is filtered onto the retina, leading to colour‑vision changes such as xanthopsia.

Common Causes

Several factors—related to the surgery itself, the implanted lens, or other ocular/medical conditions—can trigger xanthopsia after cataract extraction. The most frequent causes include:

• Intra‑ocular lens (IOL) material or tint: Some IOLs contain a yellow‑tint (often termed “blue‑filter” lenses) designed to reduce retinal phototoxicity. The tint may be perceived as a yellow cast.
• Post‑operative inflammation (uveitis): Inflammation can change the spectral transmission of the cornea and aqueous humor.
• Residual cataract fragments or posterior capsule opacification (PCO): Scattered light from remaining lens material can shift colour perception.
• Corneal edema or haze: Swelling after surgery distorts light transmission, sometimes presenting as a yellow tint.
• Medications: Topical steroids, non‑steroidal anti‑inflammatory drugs (NSAIDs), or systemic drugs such as triazolam and certain antibiotics can affect colour vision.
• Retinal or optic‑nerve disease: Pre‑existing conditions (e.g., age‑related macular degeneration, diabetic retinopathy) may become more noticeable once the cataract is removed.
• Dry eye or ocular surface disease: An irregular tear film can cause light scatter that is interpreted as a colour shift.
• Vitreal changes: Vitreous prolapse or floaters after surgery can cast shadows that appear yellowish.
• Systemic diseases: Liver dysfunction, jaundice, or certain metabolic disorders can alter colour perception, sometimes unmasked after surgery.
• Psychological factors: Anxiety or stress after surgery may heighten awareness of visual anomalies.

Associated Symptoms

Patients with post‑cataract‑surgery xanthopsia often report additional visual or ocular sensations. Common associated symptoms include:

• Glare or halos around lights, especially at night.
• Reduced contrast sensitivity (difficulty distinguishing shades of gray).
• Blurry or hazy vision that improves with time.
• Eye discomfort, burning, or a gritty feeling.
• Photophobia (light sensitivity).
• Fluctuating vision throughout the day.
• Dryness or foreign‑body sensation.
• Occasional floaters or flashing lights (if vitreous changes are present).

When to See a Doctor

Most colour‑vision changes after cataract surgery resolve within a few weeks, but certain signs warrant prompt evaluation:

• Yellow tint that persists longer than 4–6 weeks.
• Sudden worsening of vision or new “black spots,” flashes, or “curtain‑like” shadows.
• Pain, redness, or swelling of the eye.
• Significant decrease in visual acuity (e.g., from 20/30 to 20/100).
• Difficulty performing daily tasks that rely on colour discrimination (driving, reading medication labels).
• Systemic symptoms such as fever, malaise, or jaundice, which may suggest an underlying medical condition.

If any of these occur, contact your ophthalmologist or seek urgent care.

Diagnosis

Diagnosing xanthopsia involves a systematic approach to rule out reversible causes and identify any underlying ocular pathology.

1. Comprehensive History

• Timing of symptom onset relative to surgery.
• Type of IOL implanted (material, colour filter).
• Post‑operative medication regimen.
• Past ocular history (glaucoma, macular disease, dry eye).
• Systemic health (liver disease, medication use).

2. Visual‑Acuity and Refraction Test

Standard Snellen or logMAR charts determine whether vision loss accompanies the colour change.

3. Colour Vision Testing

• Farnsworth‑Munsell 100‑Hue Test or Ishihara plates to quantify the degree of yellow bias.
• Computer‑based colour‑contrast assessments (e.g., Colour Contrast Sensitivity Test).

4. Slit‑Lamp Examination

Evaluates corneal clarity, presence of edema, IOL position, and anterior chamber inflammation.

5. Dilated Fundus Examination

Assesses the retina, macula, optic nerve, and checks for posterior capsule opacification or vitreous changes.

6. Imaging (if indicated)

• Optical Coherence Tomography (OCT) – to rule out macular edema or epiretinal membrane.
• Ultrasound B‑scan – if media opacity limits view of the posterior segment.

7. Laboratory Tests (rare)

When systemic disease is suspected, liver function tests or metabolic panels may be ordered.

Treatment Options

Management depends on the identified cause. In many cases, reassurance and observation are sufficient, but specific interventions can accelerate recovery.

1. Observation & Reassurance

For mild, transient xanthopsia related to a blue‑filter IOL, doctors often advise “watchful waiting” for 4–6 weeks as the eye adapts.

2. Anti‑Inflammatory Therapy

• Topical steroids: Prednisolone acetate 1% drops, typically 4–6 times daily for 1–2 weeks, then taper.
• NSAID eye drops: Bromfenac or nepafenac to reduce prostaglandin‑mediated inflammation.

3. Management of Corneal Edema

• Hypertonic saline (5% NaCl) eye drops or ointment.
• Short course of oral acetazolamide (if medically appropriate).

4. IOL‑Related Adjustments

• If a tinted IOL is the culprit and the yellow cast is bothersome, a laser capsulotomy can be performed to address posterior capsule opacification, sometimes improving colour perception.
• In rare, refractory cases, IOL exchange may be considered after thorough counselling.

5. Treatment of Underlying Retinal Disease

Addressing concurrent macular degeneration, diabetic macular edema, or optic‑nerve pathology with anti‑VEGF injections, laser therapy, or systemic control of diabetes may improve colour vision.

6. Dry‑Eye Therapy

• Preservative‑free artificial tears (4–6 times daily).
• Lid hygiene and omega‑3 supplementation.
• In‑office punctal plugs for severe dryness.

7. Lifestyle & Home Measures

• Avoid bright, direct sunlight without proper UV‑protective sunglasses.
• Use high‑contrast settings on electronic devices (larger fonts, dark mode).
• Take scheduled breaks during prolonged screen use (20‑20‑20 rule).

Prevention Tips

While not all cases can be avoided, several strategies lower the risk of post‑operative xanthopsia:

• Pre‑operative counseling: Discuss IOL options, especially the presence of a blue‑filter tint.
• Meticulous surgical technique: Minimize corneal trauma and ensure proper IOL centration.
• Control inflammation early: Adhere to prescribed steroid/NSAID regimens.
• Maintain ocular surface health: Treat pre‑existing dry eye before surgery.
• Post‑operative follow‑up: Attend all scheduled visits so early complications are detected.
• Systemic health optimisation: Manage diabetes, hypertension, and liver disease before and after surgery.
• Avoid self‑medication: Never start or stop eye drops without professional guidance.

Emergency Warning Signs

Key Take‑aways

Xanthopsia after cataract surgery is most often a temporary side‑effect of the intra‑ocular lens or early postoperative inflammation. A thorough eye exam, appropriate anti‑inflammatory therapy, and attention to ocular surface health resolve the majority of cases within weeks. Persistent or worsening yellow‑tinted vision, especially when accompanied by pain, sudden visual loss, or systemic signs, requires urgent evaluation.

For reliable information, consult reputable sources such as the Mayo Clinic, the CDC, the NIH, the Cleveland Clinic, and peer‑reviewed ophthalmology journals.

```